1. Home
  2. EDSA vs OMH Comparison

EDSA vs OMH Comparison

Compare EDSA & OMH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • OMH
  • Stock Information
  • Founded
  • EDSA 2015
  • OMH 2015
  • Country
  • EDSA Canada
  • OMH Singapore
  • Employees
  • EDSA N/A
  • OMH N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • OMH Real Estate
  • Sector
  • EDSA Health Care
  • OMH Finance
  • Exchange
  • EDSA Nasdaq
  • OMH Nasdaq
  • Market Cap
  • EDSA 13.8M
  • OMH 13.6M
  • IPO Year
  • EDSA N/A
  • OMH 2023
  • Fundamental
  • Price
  • EDSA $2.03
  • OMH $1.45
  • Analyst Decision
  • EDSA Strong Buy
  • OMH Hold
  • Analyst Count
  • EDSA 2
  • OMH 1
  • Target Price
  • EDSA $13.00
  • OMH N/A
  • AVG Volume (30 Days)
  • EDSA 33.4K
  • OMH 5.5M
  • Earning Date
  • EDSA 08-08-2025
  • OMH 07-11-2025
  • Dividend Yield
  • EDSA N/A
  • OMH N/A
  • EPS Growth
  • EDSA N/A
  • OMH N/A
  • EPS
  • EDSA N/A
  • OMH N/A
  • Revenue
  • EDSA N/A
  • OMH $7,976,578.00
  • Revenue This Year
  • EDSA N/A
  • OMH $28.40
  • Revenue Next Year
  • EDSA N/A
  • OMH $23.07
  • P/E Ratio
  • EDSA N/A
  • OMH N/A
  • Revenue Growth
  • EDSA N/A
  • OMH 117.53
  • 52 Week Low
  • EDSA $1.55
  • OMH $0.59
  • 52 Week High
  • EDSA $5.59
  • OMH $6.20
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 52.89
  • OMH 46.11
  • Support Level
  • EDSA $1.91
  • OMH $1.45
  • Resistance Level
  • EDSA $2.14
  • OMH $1.59
  • Average True Range (ATR)
  • EDSA 0.12
  • OMH 0.40
  • MACD
  • EDSA 0.02
  • OMH 0.02
  • Stochastic Oscillator
  • EDSA 64.52
  • OMH 35.76

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About OMH Ohmyhome Limited

Ohmyhome Ltd is a data and technology-driven property technology company based in Singapore. Through its subsidiaries, it operates a one-stop-shop property platform that provides end-to-end property solutions and services for its customers, which comprises brokerage services and emerging and other services, such as home renovation and furnishing services, listing and research, mortgage referral, legal services, and insurance referral services. The company derives its revenues from two sources: revenue from brokerage services, property management services, and revenue from emerging and other services.

Share on Social Networks: